Part 1
Part 2
Part 3
Part 5
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing. The global Clinical Mass Spectrometry market is projected to reach US$ 1647.8 million by 2030 from an estimated US$ 925.1 million in 2024, at a CAGR of 10.1% during 2024 and 2030.
Clinical Mass Spectrometry Market Size
M= millions and B=billions
Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research. Report Scope This report aims to provide a comprehensive presentation of the global market for Clinical Mass Spectrometry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Clinical Mass Spectrometry. The Clinical Mass Spectrometry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Mass Spectrometry market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Clinical Mass Spectrometry manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions. Market Segmentation
Report Metric
Details
Report Title
Global Clinical Mass Spectrometry Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Forecasted Market Size in 2030
US$ 1647.8 million
CAGR(2024-2030)
10.1%
Market Size Available for Years
2019-2030
Global Clinical Mass Spectrometry Companies Covered
Danaher, Bruker, Agilent, Thermo Fisher, Waters, Shidmazu, Perkin Elmer
Global Clinical Mass Spectrometry Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Mass Spectrometry Market, Segment by Type
LC-MS
MALDI-TOF MS
Other
Global Clinical Mass Spectrometry Market, Segment by Application
Clinical Diagnostics
Clinical Research
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Sales (consumption), revenue of Clinical Mass Spectrometry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 3: Detailed analysis of Clinical Mass Spectrometry manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Mass Spectrometry sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc. Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment. Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment. Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment. Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment. Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment. Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers. Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Clinical Mass Spectrometry Product Introduction
1.2 Market by Type
1.2.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 LC-MS
1.2.3 MALDI-TOF MS
1.2.4 Other
1.3 Market by Application
1.3.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Clinical Diagnostics
1.3.3 Clinical Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Clinical Mass Spectrometry Market Size Estimates and Forecasts
2.1.1 Global Clinical Mass Spectrometry Revenue 2019-2030
2.1.2 Global Clinical Mass Spectrometry Sales 2019-2030
2.2 Clinical Mass Spectrometry Market Size by Region: 2023 Versus 2030
2.3 Clinical Mass Spectrometry Sales by Region (2019-2030)
2.3.1 Global Clinical Mass Spectrometry Sales by Region: 2019-2024
2.3.2 Global Clinical Mass Spectrometry Sales Forecast by Region (2025-2030)
2.3.3 Global Clinical Mass Spectrometry Sales Market Share by Region (2019-2030)
2.4 Clinical Mass Spectrometry Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Clinical Mass Spectrometry Revenue by Region: 2019-2024
2.4.2 Global Clinical Mass Spectrometry Revenue Forecast by Region (2025-2030)
2.4.3 Global Clinical Mass Spectrometry Revenue Market Share by Region (2019-2030)
3 Global Clinical Mass Spectrometry by Manufacturers
3.1 Global Top Clinical Mass Spectrometry Manufacturers by Sales
3.1.1 Global Clinical Mass Spectrometry Sales by Manufacturer (2019-2024)
3.1.2 Global Clinical Mass Spectrometry Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Clinical Mass Spectrometry Manufacturers by Revenue
3.2.1 Global Clinical Mass Spectrometry Revenue by Manufacturer (2019-2024)
3.2.2 Global Clinical Mass Spectrometry Revenue Share by Manufacturer (2019-2024)
3.3 Global Clinical Mass Spectrometry Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Clinical Mass Spectrometry Manufacturers Covered: Ranking by Revenue
3.4.2 Global Clinical Mass Spectrometry Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Clinical Mass Spectrometry Manufacturing Base Distribution, Product Type
3.5.1 Clinical Mass Spectrometry Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Clinical Mass Spectrometry Product Type
3.5.3 Date of International Manufacturers Enter into Clinical Mass Spectrometry Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Danaher
4.1.1 Danaher Company Information
4.1.2 Danaher Description, Business Overview
4.1.3 Danaher Clinical Mass Spectrometry Products Offered
4.1.4 Danaher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Danaher Clinical Mass Spectrometry Sales by Product in 2023
4.1.6 Danaher Clinical Mass Spectrometry Sales by Application in 2023
4.1.7 Danaher Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.1.8 Danaher Recent Developments
4.2 Bruker
4.2.1 Bruker Company Information
4.2.2 Bruker Description, Business Overview
4.2.3 Bruker Clinical Mass Spectrometry Products Offered
4.2.4 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Bruker Clinical Mass Spectrometry Sales by Product in 2023
4.2.6 Bruker Clinical Mass Spectrometry Sales by Application in 2023
4.2.7 Bruker Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.2.8 Bruker Recent Developments
4.3 Agilent
4.3.1 Agilent Company Information
4.3.2 Agilent Description, Business Overview
4.3.3 Agilent Clinical Mass Spectrometry Products Offered
4.3.4 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Agilent Clinical Mass Spectrometry Sales by Product in 2023
4.3.6 Agilent Clinical Mass Spectrometry Sales by Application in 2023
4.3.7 Agilent Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.3.8 Agilent Recent Developments
4.4 Thermo Fisher
4.4.1 Thermo Fisher Company Information
4.4.2 Thermo Fisher Description, Business Overview
4.4.3 Thermo Fisher Clinical Mass Spectrometry Products Offered
4.4.4 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Thermo Fisher Clinical Mass Spectrometry Sales by Product in 2023
4.4.6 Thermo Fisher Clinical Mass Spectrometry Sales by Application in 2023
4.4.7 Thermo Fisher Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.4.8 Thermo Fisher Recent Developments
4.5 Waters
4.5.1 Waters Company Information
4.5.2 Waters Description, Business Overview
4.5.3 Waters Clinical Mass Spectrometry Products Offered
4.5.4 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Waters Clinical Mass Spectrometry Sales by Product in 2023
4.5.6 Waters Clinical Mass Spectrometry Sales by Application in 2023
4.5.7 Waters Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.5.8 Waters Recent Developments
4.6 Shidmazu
4.6.1 Shidmazu Company Information
4.6.2 Shidmazu Description, Business Overview
4.6.3 Shidmazu Clinical Mass Spectrometry Products Offered
4.6.4 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Shidmazu Clinical Mass Spectrometry Sales by Product in 2023
4.6.6 Shidmazu Clinical Mass Spectrometry Sales by Application in 2023
4.6.7 Shidmazu Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.6.8 Shidmazu Recent Development
4.7 Perkin Elmer
4.7.1 Perkin Elmer Company Information
4.7.2 Perkin Elmer Description, Business Overview
4.7.3 Perkin Elmer Clinical Mass Spectrometry Products Offered
4.7.4 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Perkin Elmer Clinical Mass Spectrometry Sales by Product in 2023
4.7.6 Perkin Elmer Clinical Mass Spectrometry Sales by Application in 2023
4.7.7 Perkin Elmer Clinical Mass Spectrometry Sales by Geographic Area in 2023
4.7.8 Perkin Elmer Recent Development
5 Breakdown Data by Type
5.1 Global Clinical Mass Spectrometry Sales by Type (2019-2030)
5.1.1 Global Clinical Mass Spectrometry Sales by Type (2019-2024)
5.1.2 Global Clinical Mass Spectrometry Sales Forecast by Type (2025-2030)
5.1.3 Global Clinical Mass Spectrometry Sales Market Share by Type (2019-2030)
5.2 Global Clinical Mass Spectrometry Revenue Forecast by Type (2019-2030)
5.2.1 Global Clinical Mass Spectrometry Revenue by Type (2019-2024)
5.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Type (2025-2030)
5.2.3 Global Clinical Mass Spectrometry Revenue Market Share by Type (2019-2030)
5.3 Clinical Mass Spectrometry Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Clinical Mass Spectrometry Sales by Application (2019-2030)
6.1.1 Global Clinical Mass Spectrometry Sales by Application (2019-2024)
6.1.2 Global Clinical Mass Spectrometry Sales Forecast by Application (2025-2030)
6.1.3 Global Clinical Mass Spectrometry Sales Market Share by Application (2019-2030)
6.2 Global Clinical Mass Spectrometry Revenue Forecast by Application (2019-2030)
6.2.1 Global Clinical Mass Spectrometry Revenue by Application (2019-2024)
6.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Application (2025-2030)
6.2.3 Global Clinical Mass Spectrometry Revenue Market Share by Application (2019-2030)
6.3 Clinical Mass Spectrometry Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
7.2 North America Clinical Mass Spectrometry Market Facts & Figures by Country
7.2.1 North America Clinical Mass Spectrometry Sales by Country (2019-2030)
7.2.2 North America Clinical Mass Spectrometry Revenue by Country (2019-2030)
7.3 North America Clinical Mass Spectrometry Sales by Type (2019-2024)
7.4 North America Clinical Mass Spectrometry Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Clinical Mass Spectrometry Market Facts & Figures by Region
8.2.1 Asia-Pacific Clinical Mass Spectrometry Sales by Region (2019-2030)
8.2.2 Asia-Pacific Clinical Mass Spectrometry Revenue by Region (2019-2030)
8.3 Asia-Pacific Clinical Mass Spectrometry Sales by Type (2019-2024)
8.4 Asia-Pacific Clinical Mass Spectrometry Sales by Application (2019-2024)
9 Europe
9.1 Europe Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
9.2 Europe Clinical Mass Spectrometry Market Facts & Figures by Country
9.2.1 Europe Clinical Mass Spectrometry Sales by Country (2019-2030)
9.2.2 Europe Clinical Mass Spectrometry Revenue by Country (2019-2030)
9.3 Europe Clinical Mass Spectrometry Sales by Type (2019-2024)
9.4 Europe Clinical Mass Spectrometry Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
10.2 Latin America Clinical Mass Spectrometry Market Facts & Figures by Country
10.2.1 Latin America Clinical Mass Spectrometry Sales by Country (2019-2030)
10.2.2 Latin America Clinical Mass Spectrometry Revenue by Country (2019-2030)
10.3 Latin America Clinical Mass Spectrometry Sales by Type (2019-2024)
10.4 Latin America Clinical Mass Spectrometry Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Clinical Mass Spectrometry Market Facts & Figures by Country
11.2.1 Middle East and Africa Clinical Mass Spectrometry Sales by Country (2019-2030)
11.2.2 Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2019-2030)
11.3 Middle East and Africa Clinical Mass Spectrometry Sales by Type (2019-2024)
11.4 Middle East and Africa Clinical Mass Spectrometry Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Clinical Mass Spectrometry Supply Chain Analysis
12.2 Clinical Mass Spectrometry Key Raw Materials and Upstream Suppliers
12.3 Clinical Mass Spectrometry Clients Analysis
12.4 Clinical Mass Spectrometry Sales Channel and Sales Model Analysis
12.4.1 Clinical Mass Spectrometry Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Clinical Mass Spectrometry Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Clinical Mass Spectrometry Distributors
13 Market Dynamics
13.1 Clinical Mass Spectrometry Industry Trends
13.2 Clinical Mass Spectrometry Market Drivers
13.3 Clinical Mass Spectrometry Market Challenges
13.4 Clinical Mass Spectrometry Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables Table 1. Global Clinical Mass Spectrometry Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Major Manufacturers of LC-MS Table 3. Major Manufacturers of MALDI-TOF MS Table 4. Major Manufacturers of Other Table 5. Global Clinical Mass Spectrometry Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Clinical Mass Spectrometry Market Size by Region (US$ Million): 2023 VS 2030 Table 7. Global Clinical Mass Spectrometry Sales by Region (2019-2024) & (K Units) Table 8. Global Clinical Mass Spectrometry Sales Forecast by Region (2025-2030) & (K Units) Table 9. Global Clinical Mass Spectrometry Revenue by Region (2019-2024) & (US$ Million) Table 10. Global Clinical Mass Spectrometry Revenue Forecast by Region (2025-2030) & (US$ Million) Table 11. Global Clinical Mass Spectrometry Sales by Manufacturer (2019-2024) & (K Units) Table 12. Global Clinical Mass Spectrometry Sales Share by Manufacturer (2019-2024) Table 13. Clinical Mass Spectrometry Revenue by Manufacturer (2019-2024) & (US$ Million) Table 14. Clinical Mass Spectrometry Revenue Share by Manufacturer (2019-2024) Table 15. Key Manufacturers Clinical Mass Spectrometry Price (2019-2024) & (USD/Unit) Table 16. Ranking of Global Top Clinical Mass Spectrometry Manufacturers by Revenue (US$ Million) in 2023 Table 17. Global Clinical Mass Spectrometry Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024) Table 18. Global Clinical Mass Spectrometry by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2023) Table 19. Clinical Mass Spectrometry Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Clinical Mass Spectrometry Product Type Table 21. Date of International Manufacturers Enter into Clinical Mass Spectrometry Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Danaher Company Information Table 24. Danaher Description and Business Overview Table 25. Danaher Clinical Mass Spectrometry Product Table 26. Danaher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 27. Danaher Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 28. Danaher Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 29. Danaher Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 30. Danaher Recent Development Table 31. Bruker Company Information Table 32. Bruker Description and Business Overview Table 33. Bruker Clinical Mass Spectrometry Product Table 34. Bruker Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 35. Bruker Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 36. Bruker Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 37. Bruker Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 38. Bruker Recent Development Table 39. Agilent Company Information Table 40. Agilent Description and Business Overview Table 41. Agilent Clinical Mass Spectrometry Product Table 42. Agilent Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 43. Agilent Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 44. Agilent Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 45. Agilent Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 46. Agilent Recent Development Table 47. Thermo Fisher Company Information Table 48. Thermo Fisher Description and Business Overview Table 49. Thermo Fisher Clinical Mass Spectrometry Product Table 50. Thermo Fisher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 51. Thermo Fisher Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 52. Thermo Fisher Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 53. Thermo Fisher Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 54. Thermo Fisher Recent Development Table 55. Waters Company Information Table 56. Waters Description and Business Overview Table 57. Waters Clinical Mass Spectrometry Product Table 58. Waters Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 59. Waters Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 60. Waters Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 61. Waters Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 62. Waters Recent Development Table 63. Shidmazu Company Information Table 64. Shidmazu Description and Business Overview Table 65. Shidmazu Clinical Mass Spectrometry Product Table 66. Shidmazu Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 67. Shidmazu Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 68. Shidmazu Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 69. Shidmazu Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 70. Shidmazu Recent Development Table 71. Perkin Elmer Company Information Table 72. Perkin Elmer Description and Business Overview Table 73. Perkin Elmer Clinical Mass Spectrometry Product Table 74. Perkin Elmer Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 75. Perkin Elmer Sales Proportion of Clinical Mass Spectrometry by Product in 2023 Table 76. Perkin Elmer Sales Proportion of Clinical Mass Spectrometry by Application in 2023 Table 77. Perkin Elmer Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2023 Table 78. Perkin Elmer Recent Development Table 79. Global Clinical Mass Spectrometry Sales by Type (2019-2024) & (K Units) Table 80. Global Clinical Mass Spectrometry Sales Forecast by Type (2025-2030) & (K Units) Table 81. Global Clinical Mass Spectrometry Revenue by Type (2019-2024) & (US$ Million) Table 82. Global Clinical Mass Spectrometry Revenue Forecast by Type (2025-2030) & (US$ Million) Table 83. Global Clinical Mass Spectrometry Sales by Application (2019-2024) & (K Units) Table 84. Global Clinical Mass Spectrometry Sales Forecast by Application (2025-2030) & (K Units) Table 85. Global Clinical Mass Spectrometry Revenue by Application (2019-2024) & (US$ Million) Table 86. Global Clinical Mass Spectrometry Revenue Forecast by Application (2025-2030) & (US$ Million) Table 87. North America Clinical Mass Spectrometry Sales by Country (2019-2024) & (K Units) Table 88. North America Clinical Mass Spectrometry Sales by Country (2025-2030) & (K Units) Table 89. North America Clinical Mass Spectrometry Revenue by Country (2019-2024) & (US$ Million) Table 90. North America Clinical Mass Spectrometry Revenue by Country (2025-2030) & (US$ Million) Table 91. North America Clinical Mass Spectrometry Sales by Type (2019-2024) & (K Units) Table 92. North America Clinical Mass Spectrometry Sales by Application (2019-2024) & (K Units) Table 93. Asia-Pacific Clinical Mass Spectrometry Sales by Region (2019-2024) & (K Units) Table 94. Asia-Pacific Clinical Mass Spectrometry Sales by Region (2025-2030) & (K Units) Table 95. Asia-Pacific Clinical Mass Spectrometry Revenue by Region (2019-2030) & (US$ Million) Table 96. Asia-Pacific Clinical Mass Spectrometry Revenue by Region (2025-2030) & (US$ Million) Table 97. Asia-Pacific Clinical Mass Spectrometry Sales by Type (2019-2024) & (K Units) Table 98. Asia-Pacific Clinical Mass Spectrometry Sales by Application (2019-2024) & (K Units) Table 99. Europe Clinical Mass Spectrometry Sales by Country (2019-2024) & (K Units) Table 100. Europe Clinical Mass Spectrometry Sales by Country (2025-2030) & (K Units) Table 101. Europe Clinical Mass Spectrometry Revenue by Country (2019-2024) & (US$ Million) Table 102. Europe Clinical Mass Spectrometry Revenue by Country (2025-2030) & (US$ Million) Table 103. Europe Clinical Mass Spectrometry Sales by Type (2019-2024) & (K Units) Table 104. Europe Clinical Mass Spectrometry Sales by Application (2019-2024) & (K Units) Table 105. Latin America Clinical Mass Spectrometry Sales by Country (2019-2024) & (K Units) Table 106. Latin America Clinical Mass Spectrometry Sales by Country (2025-2030) & (K Units) Table 107. Latin America Clinical Mass Spectrometry Revenue by Country (2019-2024) & (US$ Million) Table 108. Latin America Clinical Mass Spectrometry Revenue by Country (2025-2030) & (US$ Million) Table 109. Latin America Clinical Mass Spectrometry Sales by Type (2019-2024) & (K Units) Table 110. Latin America Clinical Mass Spectrometry Sales by Application (2019-2024) & (K Units) Table 111. Middle East and Africa Clinical Mass Spectrometry Sales by Country (2019-2024) & (K Units) Table 112. Middle East and Africa Clinical Mass Spectrometry Sales by Country (2025-2030) & (K Units) Table 113. Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2019-2024) & (US$ Million) Table 114. Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2025-2030) & (US$ Million) Table 115. Middle East and Africa Clinical Mass Spectrometry Sales by Type (2019-2024) & (K Units) Table 116. Middle East and Africa Clinical Mass Spectrometry Sales by Application (2019-2024) & (K Units) Table 117. Clinical Mass Spectrometry Key Raw Materials, Industry Status and Trend Table 118. Clinical Mass Spectrometry Key Raw Materials and Upstream Suppliers Table 119. Clinical Mass Spectrometry Clients Status and Trend Table 120. Clinical Mass Spectrometry Typical Clients Table 121. Clinical Mass Spectrometry Distributors Table 122. Clinical Mass Spectrometry Market Trends Table 123. Clinical Mass Spectrometry Market Drivers Table 124. Clinical Mass Spectrometry Market Challenges Table 125. Clinical Mass Spectrometry Market Restraints Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Clinical Mass Spectrometry Product Picture Figure 2. Global Clinical Mass Spectrometry Sales Market Share by Type in 2023 & 2030 Figure 3. LC-MS Product Picture Figure 4. MALDI-TOF MS Product Picture Figure 5. Other Product Picture Figure 6. Global Clinical Mass Spectrometry Sales Market Share by Application in 2023 & 2030 Figure 7. Clinical Diagnostics Examples Figure 8. Clinical Research Examples Figure 9. Clinical Mass Spectrometry Report Years Considered Figure 10. Global Clinical Mass Spectrometry Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 11. Global Clinical Mass Spectrometry Market Size 2019-2030 (US$ Million) Figure 12. Global Clinical Mass Spectrometry Sales 2019-2030 (K Units) Figure 13. Global Clinical Mass Spectrometry Sales Market Share Forecast by Region (2019-2030) Figure 14. Global Clinical Mass Spectrometry Revenue Market Share by Region (2019-2030) Figure 15. Global Clinical Mass Spectrometry Sales Share by Manufacturer in 2023 Figure 16. Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023 Figure 17. Global Clinical Mass Spectrometry Sales Market Share Forecast by Type (2019-2030) Figure 18. Global Clinical Mass Spectrometry Revenue Market Share Forecast by Type (2019-2030) Figure 19. Clinical Mass Spectrometry Average Selling Price (ASP) by Type (2019-2024) & (USD/Unit) Figure 20. Global Clinical Mass Spectrometry Sales Market Share Forecast by Application (2019-2030) Figure 21. Global Clinical Mass Spectrometry Revenue Market Share Forecast by Application (2019-2030) Figure 22. Clinical Mass Spectrometry Average Selling Price (ASP) by Application (2019-2024) & (USD/Unit) Figure 23. North America Clinical Mass Spectrometry Revenue 2019-2030 (US$ Million) Figure 24. North America Clinical Mass Spectrometry Sales Market Share by Type (2019-2024) Figure 25. North America Clinical Mass Spectrometry Sales Market Share by Application (2019-2024) Figure 26. Asia-Pacific Clinical Mass Spectrometry Revenue 2019-2030 (US$ Million) Figure 27. Asia-Pacific Clinical Mass Spectrometry Sales Market Share by Region (2019-2030) Figure 28. Asia-Pacific Clinical Mass Spectrometry Revenue Market Share by Region (2019-2030) Figure 29. Asia-Pacific Clinical Mass Spectrometry Sales Market Share by Type (2019-2024) Figure 30. Asia-Pacific Clinical Mass Spectrometry Sales Market Share by Application (2019-2024) Figure 31. Europe Clinical Mass Spectrometry Revenue Growth Rate 2019-2030 (US$ Million) Figure 32. Europe Clinical Mass Spectrometry Sales Market Share by Country (2019-2030) Figure 33. Europe Clinical Mass Spectrometry Revenue Market Share by Country (2019-2030) Figure 34. Europe Clinical Mass Spectrometry Sales Market Share by Type (2019-2024) Figure 35. Europe Clinical Mass Spectrometry Sales Market Share by Application (2019-2024) Figure 36. Latin America Clinical Mass Spectrometry Revenue Growth Rate 2019-2030 (US$ Million) Figure 37. Latin America Clinical Mass Spectrometry Sales Market Share by Country (2019-2030) Figure 38. Latin America Clinical Mass Spectrometry Revenue Market Share by Country (2019-2024) Figure 39. Latin America Clinical Mass Spectrometry Sales Market Share by Type (2019-2024) Figure 40. Latin America Clinical Mass Spectrometry Sales Market Share by Application (2019-2024) Figure 41. Middle East and Africa Clinical Mass Spectrometry Revenue Growth Rate 2019-2030 (US$ Million) Figure 42. Middle East and Africa Clinical Mass Spectrometry Sales Market Share by Country (2019-2030) Figure 43. Middle East and Africa Clinical Mass Spectrometry Revenue Market Share by Country (2019-2030) Figure 44. Middle East and Africa Clinical Mass Spectrometry Sales Market Share by Type (2019-2024) Figure 45. Middle East and Africa Clinical Mass Spectrometry Sales Market Share by Application (2019-2024) Figure 46. Clinical Mass Spectrometry Supply Chain (Upstream and Downstream Market) Figure 47. Global Production Market Share of Clinical Mass Spectrometry Raw Materials by Region in 2023 Figure 48. Clinical Mass Spectrometry Distribution Channels Figure 49. Global Clinical Mass Spectrometry Percentage 2019-2030: Indirect Sales VS Direct Sales Figure 50. Global Clinical Mass Spectrometry Percentage 2019-2030: Online Sales VS Offline Sales Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing. The global Clinical Mass Spectrometry market is projected to reach US$ 1647.8 million by 2030 from an estimated US$ 925.1 million in 2024, at a CAGR of 10.1% during 2024 and 2030.
Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research. Report Scope This report aims to provide a comprehensive presentation of the global market for Clinical Mass Spectrometry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Clinical Mass Spectrometry. The Clinical Mass Spectrometry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Mass Spectrometry market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Clinical Mass Spectrometry manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions. Market Segmentation
Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Sales (consumption), revenue of Clinical Mass Spectrometry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 3: Detailed analysis of Clinical Mass Spectrometry manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Mass Spectrometry sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc. Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment. Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment. Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment. Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment. Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment. Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers. Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 14: Research Findings and Conclusion.
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now